Literature DB >> 3658137

Demyelinating disease of corpus callosum presenting as glioma on magnetic resonance scan: a case documented with pathological findings.

U P Kalyan-Raman1, D J Garwacki, P W Elwood.   

Abstract

Magnetic resonance imaging (MRI) has improved the diagnosis of several pathological entities of the brain. MRI especially has been credited with distinguishing demyelinating diseases of the central nervous system from other diseases. The presence of a mass effect in a demyelinating disorder, however, makes difficult the distinction between tumor and a demyelinating disease. We report a case of a demyelinating disorder simulating an infiltrating glioma of the corpus callosum on MRI scan, resulting in surgical intervention. To our knowledge, this is the first case to be reported with MRI and documented pathological findings.

Entities:  

Mesh:

Year:  1987        PMID: 3658137     DOI: 10.1227/00006123-198708000-00024

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  10 in total

1.  Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.

Authors:  S Cha; S Pierce; E A Knopp; G Johnson; C Yang; A Ton; A W Litt; D Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

Review 2.  Tumefactive demyelinating lesions.

Authors:  A P Dagher; J Smirniotopoulos
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

3.  Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.

Authors:  A Cianfoni; S Niku; S G Imbesi
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

4.  Pseudotumoral demyelination: a diagnosis pitfall (report of three cases).

Authors:  D Heyman; M Delhaye; D Fournier; P Mercier; M C Rousselet; P Menei
Journal:  J Neurooncol       Date:  2001-08       Impact factor: 4.130

Review 5.  Tumefactive demyelinating lesions: nine cases and a review of the literature.

Authors:  Lei Xia; Song Lin; Zhong-cheng Wang; Shao-wu Li; Li Xu; Jing Wu; Shu-yu Hao; Chuan-chuan Gao
Journal:  Neurosurg Rev       Date:  2009-01-27       Impact factor: 3.042

Review 6.  Schilder's disease: non-invasive diagnosis? :A case report and review.

Authors:  Susanna Bacigaluppi; Gabriele Polonara; Mario L Zavanone; Rolando Campanella; Vincenzo Branca; Sergio M Gaini; Giovanni Tredici; Antonella Costa
Journal:  Neurol Sci       Date:  2009-07-17       Impact factor: 3.307

7.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

Review 8.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.

Authors:  Marc C Mabray; Benjamin A Cohen; Javier E Villanueva-Meyer; Francisco E Valles; Ramon F Barajas; James L Rubenstein; Soonmee Cha
Journal:  AJR Am J Roentgenol       Date:  2015-11       Impact factor: 3.959

10.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.